JAK Inhibitor Treatment in Patients with Rheumatoid Arthritis (RA) and an Inadequate Response or Intolerance to TNF Inhibitors (TNFi-IR) Save Sponsored by AbbVie Medical Affairs Jul 01, 2022 9:00 am